Business · 17/01/2018Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 22 Abbreviated New Drug Applications from Multiple Applicants
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 22 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications from the applicants that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →